Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Janet EllisJanet EllisDr Janet Ellis completed her medical degree at Cambridge University, UK and her psychiatry residency in the UK and at University of Toronto, Canada. She is now an Assistant Professor in the Department of Psychiatry at University of Toronto and works as a Medical Psychiatrist in psychosocial oncology and acute physical trauma. She has also completed a psychoanalytic training. She was a Cancer Care Ontario Regional Clinical Lead for Psychosocial Oncology for five years and is now the Director of Psychosocial Care in Trauma at Sunnybrook Health Sciences Centre, Ontario, Canada. She has research interests in both psychosocial oncology (distress screening, integrated care, early identification of distress to improve outcomes) and trauma (prevention and management of PTSD, occupational stress injury, staff wellness). She is the psychiatry lead for the hospital's disaster planning committee and a cofounder of Disaster Psychiatry Canada. Ines B. MenjakInes B. MenjakDr Ines B. Menjak is a medical oncologist at the Sunnybrook Odette Cancer Centre in Toronto, Canada. She is the founder and medical lead of the geriatric oncology program at the Odette Cancer Centre. She also specializes in the care of patients with melanoma and lung cancer. She completed her medical training at the University of Toronto, Canada and completed a Master of Science in the Health Research Methodology Program at McMaster University, Canada. She is a recipient of the ASCO Young Investigator Award for her research in the geriatric assessment's impact on decision making for patients with early stage breast cancer. She continues her research focus on older patients with cancer, specifically the impact of geriatric assessment on functional outcomes. Sarah HalesSarah HalesSarah Hales, MD, PhD, is a psychiatrist and researcher in the Division of Psychosocial Oncology within the Department of Supportive Care at the Princess Margaret Cancer Centre and the Centre for Mental Health within the University Health Network, Canada. She is an Assistant Professor within the Department of Psychiatry at the University of Toronto, Canada. Her research has been funded by the Canadian Cancer Society, the Canadian Institutes of Health Research, and Prostate Cancer Canada/Movember. Her clinical and research interests include the end of life experience as it affects both patients and families, and psychotherapeutic interventions aimed at alleviating distress in those facing advanced disease. Together with Dr Gary Rodin, she developed Managing Cancer and Living Meaningfully (CALM), a brief psychotherapeutic intervention for patients living with the challenges of advanced disease, and a global program of further CALM development, clinician training, and research. Madeline LiMadeline LiMadeline Li MD, PhD is an Associate Professor of Psychiatry at the University of Toronto, Canada and a cancer psychiatrist and Lead of Psychosocial Oncology at the Princess Margaret Cancer Centre in Toronto, Canada. She completed an MD/PhD degree, with her doctoral studies at the Ontario Cancer Institute, followed by a residency in psychiatry and a fellowship in psychiatric oncology at the University of Toronto. In addition to clinical practice in cancer psychiatry, she conducts collaborative research in the areas of psychoneuroimmunology and psychosocial oncology. She has expertise in end of life care, emotional distress screening and management of mood disorders in cancer. She has authored several publications, guidelines and interprofessional education resources in psycho-oncology. Madeline served as the inaugural Psychosocial Oncology Clinical Lead in the Toronto South Central Local Integrative Health Network for Cancer Care Ontario. She led the development of the Distress Assessment and Response Tool (DART) program at Princess Margaret and the Medical Assistance in Dying (MAiD) service at the University Health Network in Toronto, Canada. She is currently the Medical Director on the board of the Canadian Association of Psychosocial Oncology (CAPO) and is the scientific lead for the Canadian MAiD Curriculum Development Project. Nicole BlijlevensNicole BlijlevensNicole Blijlevens is internist-hematologist, Professor in Hematology and Head of the Department of Haematology at the Radboud University Medical Centre in Nijmegen, the Netherlands. She graduated with a PhD in Medical Sciences at the Radboud University Nijmegen in 2005, with her thesis investigating mucosal barrier injury in HSCT. She continued her research in supportive care, especially focused on complications of anti-cancer treatment; MBI, citrulline and infections. She has headed various studies, co-authored different guidelines and authored more than 300 peer-reviewed publications. Andrea StringerAndrea StringerDr Andrea Stringer leads research focussing on the role of the intestine related to vitamin D. Dr Stringer's broad area of research has focussed primarily on gut function, with a focus now on linking the gut with other systems and the role of the gut microbiome in this environment. She is Deputy Director for Health and Biomedical Innovation research concentration at the University of South Australia, Australia and is Theme Leader for Gut Health. Dr Stringer's broad area of expertise is in developing strategies for preventing or treating oral and gastrointestinal damage following cancer treatments (mucositis) to reduce the burden of cancer. She has been involved in multiple pre-clinical investigations with growth factors, and probiotics to investigate their effectiveness in treating cancer treatment-induced mucositis. Dr Stringer's work has also encompassed identifying the mechanisms underpinning the damage that occurs following cancer treatments, with studies investigating the microbiome, inflammatory cytokines, the mucus barrier, and the enteric nervous system. Her current work focusses on the role of vitamin D in the intestine, specifically the effects of the microbiome, inflammatory cytokines and the mucus barrier.